Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
The New England Journal of Medicine (2016)
  • Andrew W. Roberts, Walter and Eliza Hall Institute of Medical Research
  • Matthew S. Davids, Harvard University
  • John M. Pagel, University of Washington
  • Brad S. Kahl, University of Washington
  • Soham D. Puvvada, University of Arizona
  • John F. Gerecitano, Memorial Sloan Kettering Cancer Center
  • Thomas J. Kipps, University of California, San Diego
  • Mary Ann Anderson, Royal Melbourne Hospital
  • Jennifer R. Brown, Harvard University
  • Lori Gressick
  • Shekman Wong
  • Martin Dunbar
  • Ming Zhu
  • Monali B. Desai
  • Elisa Cerri, University of Chicago
  • Sari Heitner Enschede, Rush University Medical Center
  • Rod A. Humerickhouse, Roswell Park Cancer Institute
  • William G. Wierda, University of Texas MD Anderson Cancer Center
  • John F. Seymour, Peter MacCallum Cancer Centre
Link
Disciplines
Publication Date
January 28, 2016
DOI
10.1056/NEJMoa1513257
Citation Information
Andrew W. Roberts, Matthew S. Davids, John M. Pagel, Brad S. Kahl, et al.. "Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia" The New England Journal of Medicine Vol. 374 Iss. 4 (2016) p. 311 - 322
Available at: http://works.bepress.com/john-pagel/35/